Status:
COMPLETED
Dexmedetomidine and Adenosine: Therapeutic Use for SVT
Lead Sponsor:
University of Pittsburgh
Conditions:
Supraventricular Tachycardia
Eligibility:
All Genders
5-30 years
Phase:
NA
Brief Summary
The purpose of this study is to evaluate the efficacy and safety of dexmedetomidine in the acute termination of Supraventricular Tachycardia (SVT).
Detailed Description
In 2006 the investigator found that dexmedetomidine, an alpha-2 adrenergic agonist with primarily sedative properties, possesses additional anti-arrhythmic properties. So far the investigator has foun...
Eligibility Criteria
Inclusion
- Patients between the age of 5 - 30 years old, who are scheduled for cardiac electrophysiology study for evaluation of reentrant SVT
Exclusion
- Severe Heart Failure
- Presence of of any other antiarrhythmic medication within 24 hours of enrollment
- Third degree heart block
- Sick Sinus Syndrome
Key Trial Info
Start Date :
January 1 2012
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2014
Estimated Enrollment :
22 Patients enrolled
Trial Details
Trial ID
NCT01495481
Start Date
January 1 2012
End Date
July 1 2014
Last Update
March 28 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Childrens Hospital of Pittsburgh of UPMC
Pittsburgh, Pennsylvania, United States, 15224